Clinical Trials Insight: 700029110
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 20 Apr 2009
At a glance
- Drugs MPC 9055 (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Myrexis
- 20 Apr 2009 Status changed from recruiting to active, no longer recruiting.
- 09 Feb 2009 Results presented at CROI 2009.
- 06 May 2008 Status changed from planning to recruiting according to a Myriad media release.